×
About 37,372 results

ALLMedicine™ Acute Lymphoblastic Leukemia Center

Research & Reviews  17,415 results

Strongyloides stercoralis hyperinfection in a patient with acute lymphoblastic leukemia.
https://doi.org/10.4103/jpgm.JPGM_1073_20
Journal of Postgraduate Medicine; Mishra S, Patnayak R et. al.

Apr 9th, 2021 - Strongyloides stercoralis hyperinfection in a patient with acute lymphoblastic leukemia.|2021|Mishra S,Patnayak R,Panda SS,Jena A,|

False-Positive Nonstructural Protein 1 Antigen in a Patient with Philadelphia Chromosom...
https://doi.org/10.12659/AJCR.928865
The American Journal of Case Reports; Chamnanchanunt S, Thungthong P et. al.

Apr 9th, 2021 - BACKGROUND A rapid investigation of dengue viral infection is needed for physicians who manage patients with suspected dengue infection. The nonstructural protein 1 (NS1) test kit is commonly used to diagnose patients with acute febrile illness in...

Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoie...
https://doi.org/10.1080/10428194.2021.1910688
Leukemia & Lymphoma; Pasic I, Paulson K et. al.

Apr 8th, 2021 - Allogeneic hematopoietic cell transplantation (HCT) can offer cure to some patients with acute lymphoblastic leukemia (ALL). It remains unclear how conditioning intensity affects transplant outcomes in ALL. In this retrospective study, we compared...

Is acute lymphoblastic leukemia with mature B-cell phenotype and KMT2A rearrangements a...
https://doi.org/10.1080/10428194.2021.1907375
Leukemia & Lymphoma; Hidalgo-Gómez G, Palacio-Garcia C et. al.

Apr 8th, 2021 - The association between mature B-cell phenotype and KMT2A rearrangements in acute lymphoblastic leukemia is a very rare finding. It identifies a group of patients with similar clinical and biological characteristics that clearly differs from the e...

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherap...
https://doi.org/10.1182/bloodadvances.2021004177
Blood Advances; Di Grande A, Peirs S et. al.

Apr 8th, 2021 - B-cell lymphoma 2 (BCL-2) has recently emerged as a therapeutic target for early T-cell progenitor acute lymphoblastic leukemia (ETP-ALL), a high-risk subtype of human T-cell ALL. The major clinical challenge with targeted therapeutics, such as th...

see more →

Guidelines  45 results

Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 13th, 2021 - ALL (also called acute lymphocytic leukemia) is an aggressive type of leukemia characterized by the presence of too many lymphoblasts or lymphocytes in the bone marrow and peripheral blood. It can spread to the lymph nodes, spleen, liver, central ...

Children with Down syndrome, ALL at higher risk for poor outcomes
https://www.healio.com/hematology-oncology/leukemia/news/online/{4b3c1cc4-4e4a-462e-b738-7ee6b1d20fd3}/children-with-down-syndrome-all-at-higher-risk-for-poor-outcomes

May 30th, 2020 - Children with Down syndrome and acute lymphoblastic leukemia continue to experience poorer outcomes than children with ALL who do not have Down syndrome, according to study results presented during the ASCO20 Virtual Scientific Program.

Strict Cytogenetics, MRD Criteria Identifies Pediatric B-ALL Subgroup With Favorable Prognosis
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200195/full/

May 28th, 2020 - Application of a set of stringent clinical and cytogenetic features as well as minimal residual disease (MRD) criteria can identify a subset of low-risk (LR) pediatric patients with standard-risk B-cell acute lymphoblastic leukemia (B-ALL) who can...

Tisagenlecleucel Outcomes in Trial of Pediatric, Young Adult R/R ALL Are Consistent With Those Previously Reported
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200130/full/

May 12th, 2020 - In pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) who received prior blinatumomab exposure or inotuzumab ozogamicin as bridging therapy, treatment with tisagenlecleucel is associated with consistent ...

Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelin...
https://doi.org/10.6004/jnccn.2020.0001
Journal of the National Comprehensive Cancer Network : JN... Brown P, Inaba H et. al.

Jan 7th, 2020 - Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Advancements in technology that enhance our understanding of the biology of the disease, risk-adapted therapy, and enhanced supportive care have contributed to improved su...

see more →

Drugs  201 results see all →

Clinicaltrials.gov  18,519 results

Strongyloides stercoralis hyperinfection in a patient with acute lymphoblastic leukemia.
https://doi.org/10.4103/jpgm.JPGM_1073_20
Journal of Postgraduate Medicine; Mishra S, Patnayak R et. al.

Apr 9th, 2021 - Strongyloides stercoralis hyperinfection in a patient with acute lymphoblastic leukemia.|2021|Mishra S,Patnayak R,Panda SS,Jena A,|

False-Positive Nonstructural Protein 1 Antigen in a Patient with Philadelphia Chromosom...
https://doi.org/10.12659/AJCR.928865
The American Journal of Case Reports; Chamnanchanunt S, Thungthong P et. al.

Apr 9th, 2021 - BACKGROUND A rapid investigation of dengue viral infection is needed for physicians who manage patients with suspected dengue infection. The nonstructural protein 1 (NS1) test kit is commonly used to diagnose patients with acute febrile illness in...

Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoie...
https://doi.org/10.1080/10428194.2021.1910688
Leukemia & Lymphoma; Pasic I, Paulson K et. al.

Apr 8th, 2021 - Allogeneic hematopoietic cell transplantation (HCT) can offer cure to some patients with acute lymphoblastic leukemia (ALL). It remains unclear how conditioning intensity affects transplant outcomes in ALL. In this retrospective study, we compared...

Is acute lymphoblastic leukemia with mature B-cell phenotype and KMT2A rearrangements a...
https://doi.org/10.1080/10428194.2021.1907375
Leukemia & Lymphoma; Hidalgo-Gómez G, Palacio-Garcia C et. al.

Apr 8th, 2021 - The association between mature B-cell phenotype and KMT2A rearrangements in acute lymphoblastic leukemia is a very rare finding. It identifies a group of patients with similar clinical and biological characteristics that clearly differs from the e...

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherap...
https://doi.org/10.1182/bloodadvances.2021004177
Blood Advances; Di Grande A, Peirs S et. al.

Apr 8th, 2021 - B-cell lymphoma 2 (BCL-2) has recently emerged as a therapeutic target for early T-cell progenitor acute lymphoblastic leukemia (ETP-ALL), a high-risk subtype of human T-cell ALL. The major clinical challenge with targeted therapeutics, such as th...

see more →

News  1,189 results

Allo-HSCT Plus MAb Can Boost Survival in Patients With r/r B-ALL
https://www.medscape.com/viewarticle/948153

Mar 24th, 2021 - The use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) can improve survival in minimal residual disease (MRD)-negative remission patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL) after the start...

Clear Benefit of Blinatumomab in Kids With Relapsed B-Cell Lymphoma
https://www.medscape.com/viewarticle/946711

Mar 2nd, 2021 - NEW YORK (Reuters Health) - Two randomized trials show a clear benefit of blinatumomab in combination with conventional chemotherapy in children with high-risk relapsed B-cell acute lymphoblastic leukemia (B-ALL), with improved outcomes and a favo...

TBI Beats Chemoconditioning for ALL Transplants in Children
https://www.medscape.com/viewarticle/945225

Feb 2nd, 2021 - For now at least, total body irradiation (TBI) plus etoposide remains the conditioning regimen of choice for children undergoing allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia (ALL), according to an open-label phase...

Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 13th, 2021 - ALL (also called acute lymphocytic leukemia) is an aggressive type of leukemia characterized by the presence of too many lymphoblasts or lymphocytes in the bone marrow and peripheral blood. It can spread to the lymph nodes, spleen, liver, central ...

'Impressive' Outcomes Sans Chemo in Poor-Prognosis ALL
https://www.staging.medscape.com/viewarticle/939520

Oct 20th, 2020 - The days of using chemotherapy to treat Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) may be numbered. In a phase 2 trial, up-front chemo-free induction/consolidation with the tyrosine kinase inhibitor dasatinib (Sprycel)...

see more →

Patient Education  3 results see all →